img

Global Tenofovir Disoproxil Fumarate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tenofovir Disoproxil Fumarate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tenofovir Disoproxil Fumarate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tenofovir Disoproxil Fumarate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from HIV-1 Infection and Chronic Hepatitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tenofovir Disoproxil Fumarate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tenofovir Disoproxil Fumarate key manufacturers include Glaxo SmithKline, Gilead PHARMACARE, Chengdu Brilliant Pharmaceutical, CHIA TAI TIANQING (CTTQ) Pharmaceutical, Anhui Biochem Pharmaceutical, Qilu Pharmaceutical, Cipla, Zydus Cadila and Dr Reddy's Laboratories, etc. Glaxo SmithKline, Gilead PHARMACARE, Chengdu Brilliant Pharmaceutical are top 3 players and held % sales share in total in 2022.
Tenofovir Disoproxil Fumarate can be divided into 30 Pcs/Box and 10 Pcs/Box, etc. 30 Pcs/Box is the mainstream product in the market, accounting for % sales share globally in 2022.
Tenofovir Disoproxil Fumarate is widely used in various fields, such as HIV-1 Infection, Chronic Hepatitis and Other,, etc. HIV-1 Infection provides greatest supports to the Tenofovir Disoproxil Fumarate industry development. In 2022, global % sales of Tenofovir Disoproxil Fumarate went into HIV-1 Infection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tenofovir Disoproxil Fumarate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Glaxo SmithKline
Gilead PHARMACARE
Chengdu Brilliant Pharmaceutical
CHIA TAI TIANQING (CTTQ) Pharmaceutical
Anhui Biochem Pharmaceutical
Qilu Pharmaceutical
Cipla
Zydus Cadila
Dr Reddy's Laboratories
Mylan Pharmaceuticals
Natco Pharma
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Wockhardt Ltd
Hetero Drugs
Abbott
Segment by Type
30 Pcs/Box
10 Pcs/Box

Segment by Application


HIV-1 Infection
Chronic Hepatitis
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Tenofovir Disoproxil Fumarate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tenofovir Disoproxil Fumarate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tenofovir Disoproxil Fumarate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tenofovir Disoproxil Fumarate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tenofovir Disoproxil Fumarate introduction, etc. Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Tenofovir Disoproxil Fumarate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Tenofovir Disoproxil Fumarate Market Overview
1.1 Tenofovir Disoproxil Fumarate Product Overview
1.2 Tenofovir Disoproxil Fumarate Market Segment by Type
1.2.1 30 Pcs/Box
1.2.2 10 Pcs/Box
1.3 Global Tenofovir Disoproxil Fumarate Market Size by Type
1.3.1 Global Tenofovir Disoproxil Fumarate Market Size Overview by Type (2018-2034)
1.3.2 Global Tenofovir Disoproxil Fumarate Historic Market Size Review by Type (2018-2024)
1.3.3 Global Tenofovir Disoproxil Fumarate Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2018-2024)
1.4.2 Europe Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2018-2024)
2 Global Tenofovir Disoproxil Fumarate Market Competition by Company
2.1 Global Top Players by Tenofovir Disoproxil Fumarate Sales (2018-2024)
2.2 Global Top Players by Tenofovir Disoproxil Fumarate Revenue (2018-2024)
2.3 Global Top Players by Tenofovir Disoproxil Fumarate Price (2018-2024)
2.4 Global Top Manufacturers Tenofovir Disoproxil Fumarate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tenofovir Disoproxil Fumarate Market Competitive Situation and Trends
2.5.1 Tenofovir Disoproxil Fumarate Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tenofovir Disoproxil Fumarate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate as of 2022)
2.7 Date of Key Manufacturers Enter into Tenofovir Disoproxil Fumarate Market
2.8 Key Manufacturers Tenofovir Disoproxil Fumarate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tenofovir Disoproxil Fumarate Status and Outlook by Region
3.1 Global Tenofovir Disoproxil Fumarate Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Tenofovir Disoproxil Fumarate Historic Market Size by Region
3.2.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Region (2018-2024)
3.2.2 Global Tenofovir Disoproxil Fumarate Sales in Value by Region (2018-2024)
3.2.3 Global Tenofovir Disoproxil Fumarate Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Tenofovir Disoproxil Fumarate Forecasted Market Size by Region
3.3.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Region (2024-2034)
3.3.2 Global Tenofovir Disoproxil Fumarate Sales in Value by Region (2024-2034)
3.3.3 Global Tenofovir Disoproxil Fumarate Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Tenofovir Disoproxil Fumarate by Application
4.1 Tenofovir Disoproxil Fumarate Market Segment by Application
4.1.1 HIV-1 Infection
4.1.2 Chronic Hepatitis
4.1.3 Other
4.2 Global Tenofovir Disoproxil Fumarate Market Size by Application
4.2.1 Global Tenofovir Disoproxil Fumarate Market Size Overview by Application (2018-2034)
4.2.2 Global Tenofovir Disoproxil Fumarate Historic Market Size Review by Application (2018-2024)
4.2.3 Global Tenofovir Disoproxil Fumarate Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2018-2024)
4.3.2 Europe Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2018-2024)
5 North America Tenofovir Disoproxil Fumarate by Country
5.1 North America Tenofovir Disoproxil Fumarate Historic Market Size by Country
5.1.1 North America Tenofovir Disoproxil Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2018-2024)
5.1.3 North America Tenofovir Disoproxil Fumarate Sales in Value by Country (2018-2024)
5.2 North America Tenofovir Disoproxil Fumarate Forecasted Market Size by Country
5.2.1 North America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2024-2034)
5.2.2 North America Tenofovir Disoproxil Fumarate Sales in Value by Country (2024-2034)
6 Europe Tenofovir Disoproxil Fumarate by Country
6.1 Europe Tenofovir Disoproxil Fumarate Historic Market Size by Country
6.1.1 Europe Tenofovir Disoproxil Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Tenofovir Disoproxil Fumarate Sales in Volume by Country (2018-2024)
6.1.3 Europe Tenofovir Disoproxil Fumarate Sales in Value by Country (2018-2024)
6.2 Europe Tenofovir Disoproxil Fumarate Forecasted Market Size by Country
6.2.1 Europe Tenofovir Disoproxil Fumarate Sales in Volume by Country (2024-2034)
6.2.2 Europe Tenofovir Disoproxil Fumarate Sales in Value by Country (2024-2034)
7 Asia-Pacific Tenofovir Disoproxil Fumarate by Region
7.1 Asia-Pacific Tenofovir Disoproxil Fumarate Historic Market Size by Region
7.1.1 Asia-Pacific Tenofovir Disoproxil Fumarate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Tenofovir Disoproxil Fumarate Forecasted Market Size by Region
7.2.1 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Value by Region (2024-2034)
8 Latin America Tenofovir Disoproxil Fumarate by Country
8.1 Latin America Tenofovir Disoproxil Fumarate Historic Market Size by Country
8.1.1 Latin America Tenofovir Disoproxil Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2018-2024)
8.1.3 Latin America Tenofovir Disoproxil Fumarate Sales in Value by Country (2018-2024)
8.2 Latin America Tenofovir Disoproxil Fumarate Forecasted Market Size by Country
8.2.1 Latin America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2024-2034)
8.2.2 Latin America Tenofovir Disoproxil Fumarate Sales in Value by Country (2024-2034)
9 Middle East and Africa Tenofovir Disoproxil Fumarate by Country
9.1 Middle East and Africa Tenofovir Disoproxil Fumarate Historic Market Size by Country
9.1.1 Middle East and Africa Tenofovir Disoproxil Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Tenofovir Disoproxil Fumarate Forecasted Market Size by Country
9.2.1 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Glaxo SmithKline
10.1.1 Glaxo SmithKline Company Information
10.1.2 Glaxo SmithKline Introduction and Business Overview
10.1.3 Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Glaxo SmithKline Tenofovir Disoproxil Fumarate Products Offered
10.1.5 Glaxo SmithKline Recent Development
10.2 Gilead PHARMACARE
10.2.1 Gilead PHARMACARE Company Information
10.2.2 Gilead PHARMACARE Introduction and Business Overview
10.2.3 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Products Offered
10.2.5 Gilead PHARMACARE Recent Development
10.3 Chengdu Brilliant Pharmaceutical
10.3.1 Chengdu Brilliant Pharmaceutical Company Information
10.3.2 Chengdu Brilliant Pharmaceutical Introduction and Business Overview
10.3.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered
10.3.5 Chengdu Brilliant Pharmaceutical Recent Development
10.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical
10.4.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Information
10.4.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Introduction and Business Overview
10.4.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.4.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered
10.4.5 CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development
10.5 Anhui Biochem Pharmaceutical
10.5.1 Anhui Biochem Pharmaceutical Company Information
10.5.2 Anhui Biochem Pharmaceutical Introduction and Business Overview
10.5.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered
10.5.5 Anhui Biochem Pharmaceutical Recent Development
10.6 Qilu Pharmaceutical
10.6.1 Qilu Pharmaceutical Company Information
10.6.2 Qilu Pharmaceutical Introduction and Business Overview
10.6.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered
10.6.5 Qilu Pharmaceutical Recent Development
10.7 Cipla
10.7.1 Cipla Company Information
10.7.2 Cipla Introduction and Business Overview
10.7.3 Cipla Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Cipla Tenofovir Disoproxil Fumarate Products Offered
10.7.5 Cipla Recent Development
10.8 Zydus Cadila
10.8.1 Zydus Cadila Company Information
10.8.2 Zydus Cadila Introduction and Business Overview
10.8.3 Zydus Cadila Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Zydus Cadila Tenofovir Disoproxil Fumarate Products Offered
10.8.5 Zydus Cadila Recent Development
10.9 Dr Reddy's Laboratories
10.9.1 Dr Reddy's Laboratories Company Information
10.9.2 Dr Reddy's Laboratories Introduction and Business Overview
10.9.3 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Products Offered
10.9.5 Dr Reddy's Laboratories Recent Development
10.10 Mylan Pharmaceuticals
10.10.1 Mylan Pharmaceuticals Company Information
10.10.2 Mylan Pharmaceuticals Introduction and Business Overview
10.10.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Products Offered
10.10.5 Mylan Pharmaceuticals Recent Development
10.11 Natco Pharma
10.11.1 Natco Pharma Company Information
10.11.2 Natco Pharma Introduction and Business Overview
10.11.3 Natco Pharma Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Natco Pharma Tenofovir Disoproxil Fumarate Products Offered
10.11.5 Natco Pharma Recent Development
10.12 Emcure Pharmaceuticals
10.12.1 Emcure Pharmaceuticals Company Information
10.12.2 Emcure Pharmaceuticals Introduction and Business Overview
10.12.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Products Offered
10.12.5 Emcure Pharmaceuticals Recent Development
10.13 Torrent Pharmaceuticals
10.13.1 Torrent Pharmaceuticals Company Information
10.13.2 Torrent Pharmaceuticals Introduction and Business Overview
10.13.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Products Offered
10.13.5 Torrent Pharmaceuticals Recent Development
10.14 Wockhardt Ltd
10.14.1 Wockhardt Ltd Company Information
10.14.2 Wockhardt Ltd Introduction and Business Overview
10.14.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Wockhardt Ltd Tenofovir Disoproxil Fumarate Products Offered
10.14.5 Wockhardt Ltd Recent Development
10.15 Hetero Drugs
10.15.1 Hetero Drugs Company Information
10.15.2 Hetero Drugs Introduction and Business Overview
10.15.3 Hetero Drugs Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Hetero Drugs Tenofovir Disoproxil Fumarate Products Offered
10.15.5 Hetero Drugs Recent Development
10.16 Abbott
10.16.1 Abbott Company Information
10.16.2 Abbott Introduction and Business Overview
10.16.3 Abbott Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Abbott Tenofovir Disoproxil Fumarate Products Offered
10.16.5 Abbott Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tenofovir Disoproxil Fumarate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tenofovir Disoproxil Fumarate Industrial Chain Analysis
11.4 Tenofovir Disoproxil Fumarate Market Dynamics
11.4.1 Tenofovir Disoproxil Fumarate Industry Trends
11.4.2 Tenofovir Disoproxil Fumarate Market Drivers
11.4.3 Tenofovir Disoproxil Fumarate Market Challenges
11.4.4 Tenofovir Disoproxil Fumarate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tenofovir Disoproxil Fumarate Distributors
12.3 Tenofovir Disoproxil Fumarate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 30 Pcs/Box
Table 2. Major Company of 10 Pcs/Box
Table 3. Global Tenofovir Disoproxil Fumarate Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (K Pcs)
Table 5. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (US& Million)
Table 7. Global Tenofovir Disoproxil Fumarate Market Share in Value by Type (2018-2024)
Table 8. Global Tenofovir Disoproxil Fumarate Price by Type (2018-2024) & (USD/Pcs)
Table 9. Global Tenofovir Disoproxil Fumarate Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Tenofovir Disoproxil Fumarate Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type (2024-2034)
Table 13. Global Tenofovir Disoproxil Fumarate Price by Type (2024-2034) & (USD/Pcs)
Table 14. North America Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (K Pcs)
Table 15. North America Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2018-2024)
Table 17. Europe Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Tenofovir Disoproxil Fumarate Sales by Company (2018-2024) & (K Pcs)
Table 25. Global Tenofovir Disoproxil Fumarate Sales Share by Company (2018-2024)
Table 26. Global Tenofovir Disoproxil Fumarate Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Tenofovir Disoproxil Fumarate Revenue Share by Company (2018-2024)
Table 28. Global Market Tenofovir Disoproxil Fumarate Price by Company (2018-2024) & (USD/Pcs)
Table 29. Global Tenofovir Disoproxil Fumarate Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Tenofovir Disoproxil Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate as of 2022)
Table 32. Date of Key Manufacturers Enter into Tenofovir Disoproxil Fumarate Market
Table 33. Key Manufacturers Tenofovir Disoproxil Fumarate Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Tenofovir Disoproxil Fumarate Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Tenofovir Disoproxil Fumarate Sales by Region (2018-2024) & (K Pcs)
Table 37. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Tenofovir Disoproxil Fumarate Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2018-2024)
Table 40. Global Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 41. Global Tenofovir Disoproxil Fumarate Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Tenofovir Disoproxil Fumarate Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2024-2034)
Table 45. Global Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 46. Global Tenofovir Disoproxil Fumarate Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) & (K Pcs)
Table 48. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application (2018-2024)
Table 51. Global Tenofovir Disoproxil Fumarate Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Tenofovir Disoproxil Fumarate Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Tenofovir Disoproxil Fumarate Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application (2024-2034)
Table 56. Global Tenofovir Disoproxil Fumarate Price by Application (2024-2034) & (USD/Pcs)
Table 57. North America Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) (K Pcs)
Table 58. North America Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) (K Pcs)
Table 60. Europe Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (K Pcs)
Table 68. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2018-2024)
Table 71. North America Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2024-2034)
Table 107. Glaxo SmithKline Company Information
Table 108. Glaxo SmithKline Introduction and Business Overview
Table 109. Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product
Table 111. Glaxo SmithKline Recent Development
Table 112. Gilead PHARMACARE Company Information
Table 113. Gilead PHARMACARE Introduction and Business Overview
Table 114. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product
Table 116. Gilead PHARMACARE Recent Development
Table 117. Chengdu Brilliant Pharmaceutical Company Information
Table 118. Chengdu Brilliant Pharmaceutical Introduction and Business Overview
Table 119. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product
Table 121. Chengdu Brilliant Pharmaceutical Recent Development
Table 122. CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Information
Table 123. CHIA TAI TIANQING (CTTQ) Pharmaceutical Introduction and Business Overview
Table 124. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product
Table 126. CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development
Table 127. Anhui Biochem Pharmaceutical Company Information
Table 128. Anhui Biochem Pharmaceutical Introduction and Business Overview
Table 129. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product
Table 131. Anhui Biochem Pharmaceutical Recent Development
Table 132. Qilu Pharmaceutical Company Information
Table 133. Qilu Pharmaceutical Introduction and Business Overview
Table 134. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product
Table 136. Qilu Pharmaceutical Recent Development
Table 137. Cipla Company Information
Table 138. Cipla Introduction and Business Overview
Table 139. Cipla Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Cipla Tenofovir Disoproxil Fumarate Product
Table 141. Cipla Recent Development
Table 142. Zydus Cadila Company Information
Table 143. Zydus Cadila Introduction and Business Overview
Table 144. Zydus Cadila Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Zydus Cadila Tenofovir Disoproxil Fumarate Product
Table 146. Zydus Cadila Recent Development
Table 147. Dr Reddy's Laboratories Company Information
Table 148. Dr Reddy's Laboratories Introduction and Business Overview
Table 149. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product
Table 151. Dr Reddy's Laboratories Recent Development
Table 152. Mylan Pharmaceuticals Company Information
Table 153. Mylan Pharmaceuticals Introduction and Business Overview
Table 154. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product
Table 156. Mylan Pharmaceuticals Recent Development
Table 157. Natco Pharma Company Information
Table 158. Natco Pharma Introduction and Business Overview
Table 159. Natco Pharma Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Natco Pharma Tenofovir Disoproxil Fumarate Product
Table 161. Natco Pharma Recent Development
Table 162. Emcure Pharmaceuticals Company Information
Table 163. Emcure Pharmaceuticals Introduction and Business Overview
Table 164. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product
Table 166. Emcure Pharmaceuticals Recent Development
Table 167. Torrent Pharmaceuticals Company Information
Table 168. Torrent Pharmaceuticals Introduction and Business Overview
Table 169. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 170. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product
Table 171. Torrent Pharmaceuticals Recent Development
Table 172. Wockhardt Ltd Company Information
Table 173. Wockhardt Ltd Introduction and Business Overview
Table 174. Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 175. Wockhardt Ltd Tenofovir Disoproxil Fumarate Product
Table 176. Wockhardt Ltd Recent Development
Table 177. Hetero Drugs Company Information
Table 178. Hetero Drugs Introduction and Business Overview
Table 179. Hetero Drugs Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 180. Hetero Drugs Tenofovir Disoproxil Fumarate Product
Table 181. Hetero Drugs Recent Development
Table 182. Abbott Company Information
Table 183. Abbott Introduction and Business Overview
Table 184. Abbott Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 185. Abbott Tenofovir Disoproxil Fumarate Product
Table 186. Abbott Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Tenofovir Disoproxil Fumarate Market Trends
Table 190. Tenofovir Disoproxil Fumarate Market Drivers
Table 191. Tenofovir Disoproxil Fumarate Market Challenges
Table 192. Tenofovir Disoproxil Fumarate Market Restraints
Table 193. Tenofovir Disoproxil Fumarate Distributors List
Table 194. Tenofovir Disoproxil Fumarate Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Tenofovir Disoproxil Fumarate Product Picture
Figure 2. Global Tenofovir Disoproxil Fumarate Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Tenofovir Disoproxil Fumarate Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Tenofovir Disoproxil Fumarate Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of 30 Pcs/Box
Figure 6. Global 30 Pcs/Box Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of 10 Pcs/Box
Figure 8. Global 10 Pcs/Box Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Global Tenofovir Disoproxil Fumarate Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type in 2022 & 2034
Figure 11. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2022
Figure 12. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2022
Figure 13. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2022
Figure 14. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2022
Figure 17. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Tenofovir Disoproxil Fumarate Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Tenofovir Disoproxil Fumarate Revenue in 2022
Figure 23. Tenofovir Disoproxil Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of HIV-1 Infection
Figure 25. Global HIV-1 Infection Sales YoY Growth (2018-2034) & (K Pcs)
Figure 26. Product Picture of Chronic Hepatitis
Figure 27. Global Chronic Hepatitis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Global Tenofovir Disoproxil Fumarate Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application in 2022 & 2034
Figure 32. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application in 2022
Figure 33. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2022
Figure 34. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application in 2022
Figure 35. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2022
Figure 38. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Tenofovir Disoproxil Fumarate Manufacturing Cost Structure
Figure 43. Tenofovir Disoproxil Fumarate Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries